工程平台模拟心脏发育和药物查
Madison Stiefbold1, Haokang Zhang1, Leo Q Wan2,3,4,5
1Department of Biomedical Engineering, Rensselaer Polytechnic Institute, Biotech 2147, 110 8t Street, Troy, NY, 12180, USA.
Cellular and molecular life sciences : CMLS
|April 25, 2024
概括
人类多能干细胞技术的进步使复杂的体外模型能够研究先天性心脏缺陷. 这些平台改善了对心脏发育和疾病的理解,减少了对动物模型的依赖.
科学领域:
- 发展生物学 发展生物学
- 再生医学是一种再生医学.
- 生物技术是生物技术.
背景情况:
- 先天性心脏缺陷 (CHD) 给健康带来了重大挑战,需要更好的模型来了解心脏发育.
- 人类多能干细胞 (hPSCs) 为研究人类发育和疾病提供了动物模型的强大替代品.
- 技术创新对于开发高可靠性体外平台至关重要.
研究的目的:
- 审查最近在体外平台上取得的进展,以回顾人类心脏发育.
- 突出技术创新,推动这一领域的进步.
- 分类和讨论不同类型的心脏发育平台.
主要方法:
- 审查科学文献,重点关注心脏开发平台的技术创新.
- 将平台分类为2D培养,工程基板,有机体和芯片上的胚胎模型.
- 分析干细胞生物学,基因编辑,奥米克,微流体学和传感器技术的进展.
主要成果:
- 在开发具有更高可靠性和效率的体外平台方面取得了重大进展.
- 讨论的平台包括2D培养,工程基板,心脏器官和胚胎/移植芯片模型.
- 技术创新是这些进步的关键驱动力.
结论:
- 试管心脏开发平台正在迅速发展,为心脏病研究提供了新的途径.
- 持续的技术创新对于克服当前局限性至关重要.
- 未来的前景包括进一步完善这些平台用于疾病建模和治疗开发.
相关概念视频
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...